Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

(18)F-AV-1451 and CSF T-t… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

(18)F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.

Artikel i vetenskaplig tidskrift
Författare Niklas Mattsson
Michael Schöll
Olof Strandberg
Ruben Smith
Sebastian Palmqvist
Philip S Insel
Douglas Hägerström
Tomas Ohlsson
Henrik Zetterberg
Jonas Jögi
Kaj Blennow
Oskar Hansson
Publicerad i EMBO molecular medicine
Volym 9
Nummer/häfte 9
Sidor 1212-1223
ISSN 1757-4684
Publiceringsår 2017
Publicerad vid Institutionen för neurovetenskap och fysiologi
Sidor 1212-1223
Språk en
Länkar dx.doi.org/10.15252/emmm.201707809
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämneskategorier Radiologi och bildbehandling, Klinisk laboratoriemedicin, Neurologi

Sammanfattning

To elucidate the relationship between cerebrospinal fluid (CSF) total-tau (T-tau) and phosphorylated tau (P-tau) with the tau PET ligand (18)F-AV-1451 in Alzheimer's disease (AD), we examined 30 cognitively healthy elderly (15 with preclinical AD), 14 prodromal AD, and 39 AD dementia patients. CSF T-tau and P-tau were highly correlated (R = 0.92, P < 0.001), but they were only moderately associated with retention of (18)F-AV-1451, and mainly in demented AD patients. (18)F-AV-1451, but not CSF T-tau or P-tau, was strongly associated with atrophy and cognitive impairment. CSF tau was increased in preclinical AD, despite normal (18)F-AV-1451 retention. However, not all dementia AD patients exhibited increased CSF tau, even though (18)F-AV-1451 retention was always increased at this disease stage. We conclude that CSF T-tau and P-tau mainly behave as biomarkers of "disease state", since they appear to be increased in many cases of AD at all disease stages, already before the emergence of tau aggregates. In contrast, (18)F-AV-1451 is a biomarker of "disease stage", since it is increased in clinical stages of the disease, and is associated with brain atrophy and cognitive decline.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?